- Home
- NCSM vs BRNS Comparison
NCSM vs BRNS Comparison
Compare NCSM & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCSM | BRNS |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 55.9M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NCSM | BRNS |
|---|---|---|
| Price | $39.00 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 15.6K | ★ 69.3K |
| Earning Date | 10-29-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.53 | N/A |
| Revenue | ★ $178,000,000.00 | N/A |
| Revenue This Year | $11.25 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | $8.67 | ★ N/A |
| Revenue Growth | 16.49 | ★ 1766.46 |
| 52 Week Low | $23.03 | $0.64 |
| 52 Week High | $53.69 | $2.92 |
Technical Indicators
Market Signals| Indicator | NCSM | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 38.31 |
| Support Level | $38.75 | $0.68 |
| Resistance Level | $43.01 | $0.74 |
| Average True Range (ATR) | 1.98 | 0.05 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 43.29 | 31.64 |
Price Performance
Historical ComparisonAbout NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.